The mRNA Conference 2024 is the only event to deliver leading market intelligence and industry presentations on the latest technologies and techniques for discovering, developing, and manufacturing next-generation mRNA therapeutics, formulations, and clinical development.


Benefits of attending include:

  • Two days of in-depth presentations revealing the latest market intelligence addressing the pharmaceutical industry’s collective focus by sharing results and industry experiences.
  • Exclusive networking opportunity, a chance to engage with other professionals with shared challenges and experiences in this fast-developing sector.
  • Updates on regional projects and research led by leading vaccination experts and manufacturers detailing their experiences, findings, and new proposals.
  • Technical presentations from vaccine developers showcasing the latest results from recent tests and trials, technological developments, and new technical know-how.
  • New case studies on specific examples from leading industry experts in global vaccine and treatment development initiatives.
  • Unique opportunity to integrate with a multitude of manufacturers and seek new market opportunities by demonstrating an insight into this evolving industry.


Attending this conference will enable you to:

  • Understand the current market dynamics of the biotech and pharmaceutical industry
  • Learn how to develop strategies for vaccine design and development for viable cures
  • Hear the latest trends with an overview of the year and projections for the biotech and pharmaceutical industries
  • Discuss innovations and technological developments in vaccine delivery for better immune responses
  • Access different ideas and perspectives from a multitude of experts and allied industries, combining regional experiences


Who should attend?

This event aims at leading biotech, pharmaceutical companies, government agencies, and policy think tanks seeking to learn more about innovations and technical know-how for drug discovery, development, and manufacturing. Core attendees include CEOs, COOs, CFOs, Presidents, Vice Presidents, Directors, Heads of, Superintendents, Managers, and Stakeholders involved in:


mRNA Therapeutics

Vaccine Delivery Platforms

Clinical Trials and Approvals


Biological Engineering of Vaccines

Immunization Research & Development

Blockchain Technology

Structural Vaccinology Projects

Manufacturing Research & Innovation

mRNA Technologies

Advanced Live-Attenuated Vaccines

Research and Development

Genetic Engineering

Inactivated Vaccine Development

Strategy, Projects, & Public Affairs

DNA, mRNA Technologies

Cost Reduction Strategies

Legal and Compliance Work

Viral Vector-Based Vaccines

Sales and Marketing Initiatives

Equipment Certification Services

Nucleic Acid-Based Vaccines

Business Development

News Reporting and Journalism


From the following industries and companies:

Biotechnology Companies

Global Healthcare Institutions

Associations and Alliances

Pharmaceutical Companies

Clinical Research Organizations

Universities and Academia

Vaccination Developers

Vaccine Delivery Technologies

Research and Development

Vaccine Researchers

Vaccines Manufacturing

Government Agencies

Vaccine Technology Companies

Vaccinology Research & Development

Consultants and Advisors

Immunization Specialists

Biological Engineering Companies

Public Consultation Groups

Public Healthcare Providers

DNA and Messenger RNA Researchers

Legal and Compliance Services

Genetic Engineering Companies

International Quality Standards

News Reporters and Journalists


Book now
To secure your place at The mRNA Conference 2024 or if you require more information, please contact delegates@iQ-Hub.com.

Get In Touch

Subscribe for updates:

Back to Top
  SAVE $200, Book Now!